Dermatology Times, December 2020 (Vol. 41, No. 12)

Half of patients with AD satisfied with treatment

December 16, 2020

Half of patients are satisfied with their atopic dermatitis treatment and more than half of patients worry about topical steroid side effects, addiction and withdrawal, according to a recent study.

Age discrimination in the era of COVID

December 02, 2020

In this month's Legal Eagle article, David Goldberg, MD, JD, explains how to avoid an age discrimination lawsuit from a former employee in your office by bulletproofing human resources (HR) documentation.

Adolescent acne therapies benefit younger children

December 02, 2020

A recent paper suggests younger children with acne vulgaris should be treated the same as adolescents. This includes utilizing combination therapies that may consist of topic retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics.

JAKs may predict psoriasis risk

November 27, 2020

Genetic polymorphisms may increase psoriasis susceptibility, according to a study that found patients who have the G allele in the JAK1 gene have twice the risk of developing psoriasis, and for those with the JAK3 allele, the risk rises nearly 2-fold.

Narrow-spectrum antibiotics viable treatment option for acne

November 12, 2020

Perceptions of antibiotics and potential antibiotic resistance have caused some physicians to be wary of the drug class when prescribing an acne treatment regimen. However, narrow-spectrum antibiotics have shown a low propensity for development of antimicrobial resistance while also effectively treating acne.

Venetoclax monotherapy for cutaneous BPDCN

November 11, 2020

B-cell lymphoma-2 inhibitor venetoclax has shown in clinical studies to improve symptoms with minimal toxicity in patients with cutaneous blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic cancer that can be rapidly fatal without treatment.

AI-powered diagnostic tool accurately identifies rosacea

November 10, 2020

A new artificial intelligence-powered diagnostic tool, Ros-NET, was able to accurately identify rosacea, making way for further development of the technology to aid in diagnosis of the skin condition, according to a recent study.

Age influences choice of rosacea therapies

November 05, 2020

A recent study conducted by the National Rosacea Society reveals more rosacea patients are satisfied with their treatment, but highlights the need for treatment option awareness among older patient populations.